Our study demonstrated that both mortalin mRNA and protein levels were frequently up‐regulated in ovarian cancer cells, particularly in metastatic (COC1) and drug‐resistant cell lines (A2780/cis), suggesting that mortalin plays an important role in driving aggressive ovarian cancer phenotypes. Here, HSPA9 is linked to ovarian carcinoma.